Literature DB >> 22863785

Bat3 promotes T cell responses and autoimmunity by repressing Tim-3–mediated cell death and exhaustion.

Manu Rangachari1, Chen Zhu, Kaori Sakuishi, Sheng Xiao, Jozsef Karman, Andrew Chen, Mathieu Angin, Andrew Wakeham, Edward A Greenfield, Raymond A Sobel, Hitoshi Okada, Peter J McKinnon, Tak W Mak, Marylyn M Addo, Ana C Anderson, Vijay K Kuchroo.   

Abstract

T cell immunoglobulin and mucin domain–containing 3 (Tim-3) is an inhibitory receptor that is expressed on exhausted T cells during infection with HIV-1 and hepatitis C virus. By contrast, Tim-3 expression and function are defective in multiple human autoimmune diseases. However, the molecular mechanisms modulating Tim-3 function are not well understood. Here we show that human leukocyte antigen B (HLA-B)-associated transcript 3 (Bat3) binds to, and represses the function of, Tim-3. Bat3 protects T helper type 1 (TH1) cells from galectin-9–mediated cell death and promotes both proliferation and proinflammatory cytokine production. Bat3-deficient T cells have elevated expression of exhaustion-associated molecules such as Tim-3, Lag3, Prdm1 and Pbx3, and Bat3 knockdown in myelin-antigen–specific CD4+ T cells markedly inhibits the development of experimental autoimmune encephalomyelitis while promoting the expansion of a dysfunctional Tim-3hi, interferon-γ (IFN-γ)loCD4+ cell population. Furthermore, expression of Bat3 is reduced in exhausted Tim-3+ T cells from mouse tumors and HIV-1–infected individuals. These data indicate that Bat3 acts as an inhibitor of Tim-3–dependent exhaustion and cell death. Bat3 may thus represent a viable therapeutic target in autoimmune disorders, chronic infections and cancers.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22863785      PMCID: PMC3491118          DOI: 10.1038/nm.2871

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  42 in total

Review 1.  Th1/Th2 cells.

Authors:  S Romagnani
Journal:  Inflamm Bowel Dis       Date:  1999-11       Impact factor: 5.325

2.  Reversible inhibition of Hsp70 chaperone function by Scythe and Reaper.

Authors:  K Thress; J Song; R I Morimoto; S Kornbluth
Journal:  EMBO J       Date:  2001-03-01       Impact factor: 11.598

Review 3.  Positive and negative regulation of T-cell activation through kinases and phosphatases.

Authors:  Tomas Mustelin; Kjetil Taskén
Journal:  Biochem J       Date:  2003-04-01       Impact factor: 3.857

Review 4.  T-cell exhaustion: characteristics, causes and conversion.

Authors:  John S Yi; Maureen A Cox; Allan J Zajac
Journal:  Immunology       Date:  2010-02-23       Impact factor: 7.397

5.  Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease.

Authors:  Laurent Monney; Catherine A Sabatos; Jason L Gaglia; Akemi Ryu; Hanspeter Waldner; Tatyana Chernova; Stephen Manning; Edward A Greenfield; Anthony J Coyle; Raymond A Sobel; Gordon J Freeman; Vijay K Kuchroo
Journal:  Nature       Date:  2002-01-31       Impact factor: 49.962

6.  A role for the transcriptional repressor Blimp-1 in CD8(+) T cell exhaustion during chronic viral infection.

Authors:  Haina Shin; Shawn D Blackburn; Andrew M Intlekofer; Charlly Kao; Jill M Angelosanto; Steven L Reiner; E John Wherry
Journal:  Immunity       Date:  2009-08-06       Impact factor: 31.745

7.  The apoptotic protease-activating factor 1-mediated pathway of apoptosis is dispensable for negative selection of thymocytes.

Authors:  Hiromitsu Hara; Atsunobu Takeda; Michiyo Takeuchi; Andrew C Wakeham; Annick Itié; Masafumi Sasaki; Tak W Mak; Akihiko Yoshimura; Kikuo Nomoto; Hiroki Yoshida
Journal:  J Immunol       Date:  2002-03-01       Impact factor: 5.422

Review 8.  The hepatitis C virus enigma.

Authors:  Helge Myrmel; Elling Ulvestad; Birgitta Asjø
Journal:  APMIS       Date:  2009-05       Impact factor: 3.205

9.  Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes.

Authors:  Anneli Jäger; Valérie Dardalhon; Raymond A Sobel; Estelle Bettelli; Vijay K Kuchroo
Journal:  J Immunol       Date:  2009-11-04       Impact factor: 5.422

10.  Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells.

Authors:  Lucy Golden-Mason; Brent E Palmer; Nasim Kassam; Lisa Townshend-Bulson; Stephen Livingston; Brian J McMahon; Nicole Castelblanco; Vijay Kuchroo; David R Gretch; Hugo R Rosen
Journal:  J Virol       Date:  2009-07-08       Impact factor: 5.103

View more
  140 in total

1.  CEACAM1 regulates TIM-3-mediated tolerance and exhaustion.

Authors:  Yu-Hwa Huang; Chen Zhu; Yasuyuki Kondo; Ana C Anderson; Amit Gandhi; Andrew Russell; Stephanie K Dougan; Britt-Sabina Petersen; Espen Melum; Thomas Pertel; Kiera L Clayton; Monika Raab; Qiang Chen; Nicole Beauchemin; Paul J Yazaki; Michal Pyzik; Mario A Ostrowski; Jonathan N Glickman; Christopher E Rudd; Hidde L Ploegh; Andre Franke; Gregory A Petsko; Vijay K Kuchroo; Richard S Blumberg
Journal:  Nature       Date:  2014-10-26       Impact factor: 49.962

2.  Acute stimulation generates Tim-3-expressing T helper type 1 CD4 T cells that persist in vivo and show enhanced effector function.

Authors:  Jacob V Gorman; John D Colgan
Journal:  Immunology       Date:  2018-02-08       Impact factor: 7.397

3.  TIM-3 Regulates CD103+ Dendritic Cell Function and Response to Chemotherapy in Breast Cancer.

Authors:  Álvaro de Mingo Pulido; Alycia Gardner; Shandi Hiebler; Hatem Soliman; Hope S Rugo; Matthew F Krummel; Lisa M Coussens; Brian Ruffell
Journal:  Cancer Cell       Date:  2018-01-08       Impact factor: 31.743

4.  The metabolite BH4 controls T cell proliferation in autoimmunity and cancer.

Authors:  Shane J F Cronin; Corey Seehus; Adelheid Weidinger; Sebastien Talbot; Sonja Reissig; Markus Seifert; Yann Pierson; Eileen McNeill; Maria Serena Longhi; Bruna Lenfers Turnes; Taras Kreslavsky; Melanie Kogler; David Hoffmann; Melita Ticevic; Débora da Luz Scheffer; Luigi Tortola; Domagoj Cikes; Alexander Jais; Manu Rangachari; Shuan Rao; Magdalena Paolino; Maria Novatchkova; Martin Aichinger; Lee Barrett; Alban Latremoliere; Gerald Wirnsberger; Guenther Lametschwandtner; Meinrad Busslinger; Stephen Zicha; Alexandra Latini; Simon C Robson; Ari Waisman; Nick Andrews; Michael Costigan; Keith M Channon; Guenter Weiss; Andrey V Kozlov; Mark Tebbe; Kai Johnsson; Clifford J Woolf; Josef M Penninger
Journal:  Nature       Date:  2018-11-07       Impact factor: 49.962

Review 5.  Tolerance and exhaustion: defining mechanisms of T cell dysfunction.

Authors:  Andrea Schietinger; Philip D Greenberg
Journal:  Trends Immunol       Date:  2013-11-06       Impact factor: 16.687

6.  Tim-3 promotes tumor-promoting M2 macrophage polarization by binding to STAT1 and suppressing the STAT1-miR-155 signaling axis.

Authors:  Xingwei Jiang; Tingting Zhou; Yan Xiao; Jiahui Yu; Shuaijie Dou; Guojiang Chen; Renxi Wang; He Xiao; Chunmei Hou; Wei Wang; Qingzhu Shi; Jiannan Feng; Yuanfang Ma; Beifen Shen; Yan Li; Gencheng Han
Journal:  Oncoimmunology       Date:  2016-08-03       Impact factor: 8.110

Review 7.  The Potential Role of Inhibitory Receptors in the Treatment of Psoriasis.

Authors:  Neha Shah; Sabina Sandigursky; Adam Mor
Journal:  Bull Hosp Jt Dis (2013)       Date:  2017-05

Review 8.  Tim-3, Lag-3, and TIGIT.

Authors:  Nicole Joller; Vijay K Kuchroo
Journal:  Curr Top Microbiol Immunol       Date:  2017       Impact factor: 4.291

Review 9.  Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease.

Authors:  John Attanasio; E John Wherry
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

Review 10.  Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation.

Authors:  Ana C Anderson; Nicole Joller; Vijay K Kuchroo
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.